Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Natera Inc (NQ: NTRA ) 120.65 -1.75 (-1.43%) Streaming Delayed Price Updated: 2:07 PM EDT, Oct 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Natera Inc < Previous 1 2 ... 5 6 7 8 9 10 11 12 Next > INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims on Behalf of Natera, Inc. (NTRA) Investors January 26, 2022 From Kirby McInerney LLP Via Business Wire Investigation Notice: The Schall Law Firm Encourages Investors in Natera, Inc. with Losses of $100,000 to Contact the Firm January 24, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Investigation Alert: The Schall Law Firm Encourages Investors in Natera, Inc. with Losses of $100,000 to Contact the Firm January 21, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Regulatory Compliance Exposures Legal Regulatory Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Natera, Inc. with Losses of $100,000 to Contact the Firm January 20, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Landmark SMART Study Demonstrates High Accuracy of Natera’s Panorama® NIPT for 22q11.2 Deletion Screening January 20, 2022 From Natera Via Business Wire Investigation Notice: The Schall Law Firm Encourages Investors in Natera, Inc. with Losses of $100,000 to Contact the Firm January 19, 2022 Los Angeles - (NewMediaWire) - January 19, 2022 - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Natera, Inc.... Via NewMediaWire INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Natera, Inc. with Losses of $100,000 to Contact the Firm January 19, 2022 From The Schall Law Firm Via Business Wire SHAREHOLDER ALERT: Robbins LLP Investigates Natera, Inc. (NTRA) on Behalf of Shareholders January 18, 2022 From Robbins LLP Via Business Wire INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Natera, Inc. with Losses of $100,000 to Contact the Firm January 18, 2022 From The Schall Law Firm Via Business Wire ROSEN, A LEADING LAW FIRM, Encourages Natera, Inc. Investors with Losses to Inquire About Class Action Investigation – NTRA January 17, 2022 From Rosen Law Firm Via Business Wire FeganScott Announces Investigation into Prenatal Testing Options Revealing Flawed Genetic Results January 17, 2022 --News Direct-- Via News Direct INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims on Behalf of Natera, Inc. (NTRA) Investors January 11, 2022 From Kirby McInerney LLP Via Business Wire SHAREHOLDER ALERT: Robbins LLP Investigates Natera, Inc. (NTRA) on Behalf of Shareholders January 10, 2022 From Robbins LLP Via Business Wire Stocks That Hit 52-Week Lows On Friday January 07, 2022 Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap... Via Benzinga Natera Announces Expansion Into Early Cancer Detection and Screening January 06, 2022 From Natera, Inc. Via Business Wire NATERA ALERT: Bragar Eagel & Squire, P.C. is Investigating Natera, Inc. on Behalf of Natera Stockholders and Encourages Investors to Contact the Firm January 04, 2022 From Bragar Eagel & Squire, P.C. Via Business Wire Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Natera, Inc. (NTRA) on Behalf of Investors January 03, 2022 From Glancy Prongay & Murray LLP Via Business Wire The Law Offices of Frank R. Cruz Announces Investigation of Natera, Inc. (NTRA) on Behalf of Investors January 03, 2022 From The Law Offices of Frank R. Cruz Via Business Wire INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Natera, Inc. (NTRA) on Behalf of Investors January 03, 2022 From Law Offices of Howard G. Smith Via Business Wire 7 Stocks to Buy in November in Light of Their October Dip November 15, 2021 October was a good month in the markets. It won't be easy to find stocks to buy on the dip. However, here are seven that will do the trick. Via InvestorPlace Medicare Coverage For Natera's Signatera For Pan-Cancer Immunotherapy Monitoring November 11, 2021 CMS Molecular Diagnostics Services Program (MolDX) has issued a final local coverage determination (LCD) for pan-cancer immunotherapy monitoring using Natera Inc... Via Benzinga Natera Raises FY21 Sales Outlook After Mixed Q3 earnings November 05, 2021 Natera Inc (NASDAQ: NTRA) posted Q3 sales of $158.1 million, +61% Y/Y, beating the consensus of $151.36 million, driven by an increase in test volume and product... Via Benzinga Natera Inc (NTRA) Q3 2021 Earnings Call Transcript November 05, 2021 NTRA earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial CEO And President Of Natera Trades $2.4M In Company Stock October 06, 2021 Leonard Steven Chapman, CEO And President at Natera (NASDAQ:NTRA), made a large buy and sell of company shares on October 5, according to a new SEC filing. What Happened: A Form 4... Via Benzinga Topics Regulatory Compliance Exposures Legal Regulatory Notable Natera Insider Trades $3M In Company Stock September 30, 2021 Burkes Michael Brophy, Chief Financial Officer at Natera (NASDAQ:NTRA), made a large buy and sell of company shares on September 28, according to a new SEC filing. What Happened:... Via Benzinga Topics Regulatory Compliance Exposures Legal Regulatory The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO November 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... Via Benzinga Exposures COVID-19 CEO And President Of Natera Trades $3.41 Million In Company Stock September 27, 2021 Leonard Steven Chapman, CEO And President at Natera (NASDAQ:NTRA), made a large buy and sell of company shares on September 24, according to a new SEC filing. What Happened: A... Via Benzinga Topics Regulatory Compliance Exposures Legal Regulatory The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline October 31, 2021 Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... Via Benzinga Return on Capital Employed Overview: Natera August 30, 2021 After pulling data from Benzinga Pro it seems like during Q2, Natera (NASDAQ:NTRA) brought in sales totaling $142.03 million. However, earnings decreased 82.96%, resulting in a... Via Benzinga Natera Q2 Sales Tops Street Estimates On Higher Volumes, Raises FY21 Sales Outlook August 06, 2021 Natera Inc's (NASDAQ: NTRA) second-quarter revenues jumped 64% Y/Y $142 million, driven by an increase in test volume and product revenues, sharply ahead of the consensus... Via Benzinga < Previous 1 2 ... 5 6 7 8 9 10 11 12 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.